The computational analysis suggested the predictive diagnostic and prognostic roles for both YY1 and RKIP stimulating further studies for proving their implication as novel biomarkers, as well as therapeutically druggable targets in LC. This evidence concerns the gene PEBP1 and laryngotracheoesophageal cleft.